Prostate Cancer
Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.
January 8, 2024
Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.
January 8, 2024
Clinical and functional outcomes for risk-appropriate treatments for prostate cancer.
January 8, 2024
Co-designing an online treatment decision aid for men with low-risk prostate cancer: Navigate.
January 8, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
January 8, 2024
Approach to Patients with High-Risk Localized Prostate Cancer: Radiation Oncology Perspective.
January 5, 2024
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
January 5, 2024
First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.
January 4, 2024